Juvederm vs Restylane Cost: Which Brand Gives You More for Your Budget?

juvederm vs restylane cost

The most common filler question I see in medspa marketing — beyond price alone — is the Juvederm vs. Restylane debate. Patients want to know which brand gives them more value for their budget. Medspa owners want to know how to position both product lines without confusing prospective patients or creating a price comparison problem in the consultation room. I will break down actual cost differences, what drives them, the key clinical distinctions between the two families, and how to think about the choice whether you are sitting in the patient chair or behind the treatment table.

1. Brand Overview: Juvederm and Restylane

Both Juvederm and Restylane are hyaluronic acid (HA) filler families made by different manufacturers. Juvederm is made by Allergan Aesthetics, which is an AbbVie company — the same parent company that makes Botox. Restylane is made by Galderma, which also produces Dysport and the Sculptra collagen stimulator under a separate product line. Both brands are FDA-approved, both are widely distributed through licensed US channels, and both are available in multiple product lines designed for different treatment areas, injection depths, and clinical goals. Neither is universally “better” — the right product for a specific treatment depends on the anatomy being addressed, the depth of injection, the patient’s skin quality, and the injector’s trained technique preference.

2. Per-Syringe Cost Comparison: Juvederm vs. Restylane

At the practice level, wholesale cost differences between comparable Juvederm and Restylane products are relatively small — est. $50–$150 per syringe depending on the product tier and the volume discount the practice receives from their distributor. At the patient level, what you pay is driven far more by your injector’s credential, your market, and the practice’s overhead and service model than by which brand’s name is on the box. Here is what both brands typically cost across their respective product lines at US practices in 2025:

• Juvederm Ultra / Restylane-L (entry HA, light-medium correction): est. $550–$850 per syringe at most US practices
• Juvederm Voluma / Restylane Lyft (cheek volume, structural lift): est. $700–$1,100 per syringe
• Juvederm Vollure / Restylane Defyne (moderate lift, dynamic movement tolerance): est. $650–$1,000 per syringe
• Juvederm Volbella / Restylane Kysse (lip augmentation and perioral lines): est. $600–$950 per syringe
• RHA Collection — RHA 2, 3, 4 (Galderma dynamic-movement line): est. $700–$1,100 per syringe
• Juvederm Volux (jawline and chin projection, newer indication): est. $800–$1,200 per syringe

In practice, most patients will not find a meaningful price difference between equivalent Juvederm and Restylane products at the same clinic. The spread within each brand — entry product vs. premium product — is much larger than the spread between comparable products across brands. A patient comparing Juvederm Voluma to Restylane-L is not making a like-for-like comparison; a patient comparing Juvederm Voluma to Restylane Lyft is, and those two will typically be priced within est. $75–$150 of each other at the same practice.

3. Longevity: Does One Brand Last Longer?

Longevity is the question patients expect to settle the debate in favor of one brand. The honest answer is that both product families produce comparable longevity when matched appropriately to the treatment area and injection depth. The more significant variable is patient metabolism, not brand. Here is what clinical data and real-world practice suggest for each major application area:

• Lips: Both Juvederm Volbella and Restylane Kysse average est. 6–12 months before a meaningful touch-up is needed. Kysse was specifically engineered for lip softness and natural movement and many injectors report slightly longer patient satisfaction timelines with it in the lip area, though individual results vary considerably by metabolism.
• Cheeks and midface volume: Both Voluma and Restylane Lyft are clinically rated for up to 24 months. Most patients realistically maintain an optimal result for est. 12–18 months before requesting a refresh — full 24-month results are achievable but not universal.
• Moderate lines — nasolabial folds, marionette lines: Juvederm Vollure and Restylane Defyne are both designed to flex with facial movement and typically hold for est. 12–18 months in most patients. The RHA 3 and RHA 4 products from Galderma are specifically engineered for high-movement areas and are showing strong longevity data in those zones.
• Fine lines and perioral area: Entry-tier products from both brands last est. 6–12 months in the fine-line perioral zone, where movement is constant and metabolism of filler is faster than in structural areas like the cheeks.

4. Juvederm vs. Restylane: Key Product Differences

• Gel consistency and cross-linking: Juvederm products are generally manufactured with a smoother, more homogenized gel that flows more freely during injection. Restylane products tend to have a slightly firmer, more particulate gel structure that stays more precisely where placed. Both approaches have clinical advantages depending on treatment area — softness is preferred in lips and fine perioral work; firmness is preferred for structural lift in the midface and jawline.
• Swelling pattern post-injection: Some injectors consistently report that Juvederm products absorb slightly more tissue water in the days following injection, leading to a period of initial overcorrection that resolves over one to two weeks. Restylane’s firmer gel hydrates more modestly. The clinical implication is that final results are better assessed at two weeks rather than immediately post-treatment for both brands, but the interim presentation can differ.
• Injector familiarity and technique: In the United States, Juvederm has historically held higher market share, meaning more American injectors have higher case volume with Juvederm products. Restylane is the market leader in Europe and carries a large and highly experienced US injector base as well. An injector who trained primarily on one brand will generally perform better with that brand, all else being equal. This is an underappreciated variable in the patient decision.
• Loyalty programs: Allergan’s Alle rewards program is deeply embedded in US practice marketing because Allergan also makes Botox and Latisse — patients accumulate points across all three qualifying products at most practices. Galderma’s Aspire Rewards program is similarly structured and rewards qualifying Restylane, Sculptra, Dysport, and Cetaphil purchases. Both are worth enrolling in regardless of brand preference.

5. Which Brand Costs More at Your Clinic — and Why?

If your medspa stocks both Juvederm and Restylane, the pricing difference you show patients should reflect your actual product cost differential, not a blanket brand premium applied without clinical rationale. Practices that overprice Restylane relative to Juvederm without a specific justification confuse patients and invite comparison shopping online — which always ends in someone finding a cheaper quote somewhere. The better approach is to price by treatment area and clinical function, with a brief explanatory note about why specific products are recommended for specific areas. That approach builds trust and reduces price objection simultaneously.

If you are an owner trying to figure out how product mix and pricing affects your overall revenue per treatment session, my medspa revenue calculator helps you model average ticket by treatment type across different product combinations.

6. What Drives the Price You Actually Pay

Brand choice matters less than any of the following factors when you are comparing filler quotes:

• Injector credential and experience: A board-certified plastic surgeon injecting Restylane Lyft will charge more than a nurse injecting Juvederm Voluma — and may well be the right choice for a patient with complex midface anatomy. Credential is the primary driver, not product brand.
• Market geography: The same syringe of Juvederm Voluma costs est. $850–$1,200 in Manhattan and est. $650–$850 in suburban Ohio. Brand is the same; market overhead is entirely different.
• Practice overhead model: Boutique medspas in premium real estate build their rent, staffing, and service model costs into treatment pricing regardless of which brand they use. That is not brand premium; that is overhead allocation.
• Volume of product included: A quote for “lip filler” could mean 0.5ml or 1.0ml depending on the practice standard. Always ask the exact product name and volume in milliliters before comparing quotes — a 1.0ml syringe of Restylane Kysse and a 0.5ml syringe of Juvederm Volbella are not the same comparison regardless of listed price.
• Included services: Consultation, numbing, cannula technique if applicable, and a complimentary two-week follow-up touch-up are all variable inclusions that change the effective value of any quote significantly.

7. Patient Preference: Does Brand Matter to Patients?

In my experience working with medspa owners across markets, brand awareness varies significantly by geography and patient demographic. In major metros — NYC, LA, Miami — a meaningful share of patients will arrive at consultations having already decided they want “Juvederm” or “Restylane” by name based on what a friend received or what they read online. In smaller markets, most patients defer entirely to the injector’s recommendation without a brand preference. For medspas in brand-aware markets, the consultation script matters: an injector who leads with “I prefer Restylane Defyne for nasolabial folds because its resilient gel flex factor produces more natural-looking movement compared to the alternatives” builds more confidence than “we have both, what do you prefer?” when the patient has no clinical basis for making that choice.

My full guide on medspa marketing and patient consultation strategy covers how to position your product mix to build trust, handle brand-specific questions, and drive higher average treatment tickets without creating price comparison pressure in the consultation room.

8. Which Should You Choose as a Patient?

The most honest answer available: trust your injector’s recommendation over brand loyalty you developed from social media or a friend’s experience. An experienced injector who performs two hundred Restylane treatments per year will produce better results with Restylane than with a Juvederm product they use thirty times per year — and vice versa. The product in the hands of someone who uses it daily will outperform the competing brand in someone’s hands once a month, regardless of which brand is technically “better” in a laboratory study. Ask your injector specifically what product they use most frequently for your exact treatment area, how many of those treatments they have performed, and what their reasoning is for their preference. A credentialed injector should have a clear, specific answer. Vague responses to specific questions are a signal worth noting.

9. Medspa Owner Takeaway on Juvederm vs. Restylane Pricing

Stocking both brands gives you clinical flexibility and appeals to brand-loyal patients who will not book if you only carry one family. The business risk is that patients begin treating equivalent products as interchangeable commodities and choose purely on advertised price. The counter-strategy is educational content — exactly like this article — that explains what makes individual products within each family different, why injector technique and product matching matter more than brand name, and why a practice that leads with clinical rationale earns more trust than one that leads with promotions. That content reduces price sensitivity for the patients most worth having on your roster.

10. Budget Planning for Juvederm or Restylane

• Budget est. $600–$1,500 per syringe depending on your market and provider credential — brand choice will move this est. $50–$150 within a given clinic, not the $300–$400 gap patients sometimes expect.
• Ask for the exact product name, volume in milliliters, and whether numbing, cannula if applicable, and follow-up are included before comparing quotes across practices.
• Enroll in both Alle (Allergan/Juvederm) and Aspire (Galderma/Restylane) rewards programs before booking — you can only earn on whichever brand you receive, but having both accounts active costs nothing and positions you to accumulate points regardless of which direction your injector recommends.
• If you are budget-conscious, ask specifically whether entry-level HA products — Juvederm Ultra Plus or Restylane-L — are clinically appropriate for your treatment area. They are meaningfully less expensive than premium-tier products and are the right clinical choice for many patients, particularly for surface-level correction and fine perioral work.
• Plan for a two-week follow-up before evaluating your final result — both brands have initial swelling that resolves and settling that occurs over the first fourteen days, and any touch-up decisions should be made at that visit rather than immediately post-treatment.

If you are a medspa owner looking to build a marketing and pricing strategy that converts more brand-comparison searchers into booked patients, book a free strategy consultation and I will show you exactly how I approach product positioning, price architecture, and consultation conversion for practices carrying both Juvederm and Restylane product lines.